Transfusion‑transmitted infections
10.1007/s44313-024-00014-w
- Author:
Han Joo KIM
1
;
Dae‑Hyun KO
Author Information
1. Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic‑Ro, Songpa‑Gu, Seoul 05505, Korea
- Publication Type:REVIEW
- From:Blood Research
2024;59():14-
- CountryRepublic of Korea
- Language:English
-
Abstract:
The risk of transfusion-transmitted infection (TTI) has always existed because transfused blood products are biologi‑ cal materials derived from humans. To prevent TTIs, screening strategies have been developed for various infectious diseases, such as hepatitis B virus, hepatitis C virus, and human immunodeficiency virus, contributing significantly to reducing TTI globally. Nevertheless, septic transfusion reactions (STRs) due to bacterial contamination remain an unresolved issue. Various infectious diseases can be transmitted through blood products, and preventive and selective screening strategies have been applied across different regions. Although multiple strategies, includ‑ ing culture-based and rapid detection kit-based methods, have been introduced to overcome STRs, complete preven‑ tion has not yet been achieved. Recently, pathogen inactivation methods have been developed to eliminate nonspecific organisms rather than screening specific organisms. This approach is anticipated to contribute significantly to diminishing the risk of TTIs in the future.
